Showing 4021-4030 of 5312 results for "".
- Golden State Dermatology Adds Concord Practicehttps://practicaldermatology.com/news/golden-state-dermatology-adds-concord-practice/2460850/Curtis A. Raskin, MD, PhD, FAAD and his team are now part of Golden State Dermatology. The clinic in Downtown Concord adds to the eight new locations Golden State added in 2020, after adding eight in 2019. Dr. Raskin received his medical degree and PhD in molecular biology from State Un
- Study: Skin Reactions After COVID-19 Vaccines Are Rarehttps://practicaldermatology.com/news/study-skin-reactions-after-covid-19-vaccines-are-rare/2460848/Skin problems such as itchiness, rashes, hives and swelling can occur in some individuals after receiving a COVID-19 vaccine, but new research suggests that these reactions are rare, and that even when they do occur with an initial COVID-19 vaccination, they seldom recur after receiving a second
- OMNY Health Launches Integrated Dermatology Data Repository and Research Networkhttps://practicaldermatology.com/news/omny-health-launches-integrated-dermatology-data-repository-and-research-network/2460845/OMNY Health has partnered with community-based dermatology practices to create a first-of-a-kind integrated, normalized, de-identified electronic health record (EHR) data repository for dermatological research. The assembled longitudinal data represents care delivered over the pas
- Nutrafol Launches Postpartum Formulahttps://practicaldermatology.com/news/nutrafol-launches-postpartum-formula/2460838/The first-of-its-kind postpartum hair nutraceutical is now available from Nutrafol. Nutrafol Postpartum was developed with an OB/GYN to target the root causes of excess hair shedding and thinning post-pregnancy. It is intended to help the body recover from the physical stress of childbirth,
- AAD Survey: Only a Third of Americans are Concerned about Skin Cancer Despite Nearly 70% Having at Least One Risk Factorhttps://practicaldermatology.com/news/aad-survey-only-a-third-of-americans-are-concerned-about-skin-cancer-despite-nearly-70-having-at-least-one-risk-factor/2460836/Despite skin cancer being the most common cancer in the U.S., only about one-third of adults are concerned about developing the disease, even though nearly 70 percent say they have at least one risk factor for skin cancer, according to a new American Academy of Dermatology (AAD) survey.
- Nurx Adds Rosacea Care to List of Serviceshttps://practicaldermatology.com/news/nurx-adds-rosacea-care-to-list-of-services/2460832/Nurx, now includes rosacea treatment in its at-home dermatology services. The service consists of a consultation with a Nurx medical provider, a personalized treatment plan for rosacea, home delivery of medication, and ongoing care. The expansion builds on the successful launch of Nurx&
- SkinSAFE, CVS Name Top 25 2021 Sunscreen Award Winners for Sensitive Skinhttps://practicaldermatology.com/news/skinsafe-cvs-name-top-25-2021-sunscreen-award-winners-for-sensitive-skin/2460826/SkinSAFE partnered with CVS Pharmacy, through the retailer's "Sensitive-Friendly" program, for the first-ever awards that recognize popular products that are safe for sensitive skin types. The experts at
- Parents Magazine Announces Winners of Best Skin Care for Kids 2021https://practicaldermatology.com/news/parents-magazine-announces-winners-of-best-skin-care-for-kids-2021/2460823/Meredith Corporation's Parents magazine released this year's Best Skin Care for Kids. Parents experts thoroughly tested nearly 300 formulas of parent recommendations, brand best-sellers, and new releases for skin and hair with 55 families. A total of 30 products that are a
- Dove, Conservation International Announce Million Dollar Forest Restoration Project to Fight Climate Changehttps://practicaldermatology.com/news/dove-conservation-international-announce-million-dollar-forest-restoration-project-to-fight-climate-change/2460822/Dove is launching the Dove Forest Restoration Project, one of the biggest protection and restoration efforts from any beauty brand to-date. The project is designed to protect and restore forests, protect the habitats of endangered species, and improve the livelihoods of 16,000 peo
- AstraZeneca's Anifrolumab Shows Benefit for Skin, Joint Symptoms of Lupushttps://practicaldermatology.com/news/astrazenecas-anifrolumab-shows-benefit-for-skin-joint-symptoms-of-lupus/2460819/Anifrolumab is consistently associated with improvements in both skin rash and arthritis across three different disease measures in patients with moderate to severe systemic lupus erythematosus (SLE), results of a new post-hoc analysis of pooled data from the TULIP phase 3 clinical trials show. T